Mark Fitzgerald
Company: Nested Therapeutics
Job title: Director, Chemistry
Seminars:
Validating a Hit-Finding Strategy Around the Scaffolding Function of Aurora Kinase A 2:00 pm
Leveraging an indirect method to target N-Myc through disruption of protein-protein interactions (PPIs) Assessing the landscape to date and the potential for druggable allosteric pockets along the PPI interface Enabling a comprehensive hit discovery campaign to find PPI disruptors which maintain kinase activityRead more
day: Conference Day Two